Design by trial

David V. Glidden ()
Additional contact information
David V. Glidden: University of California, San Francisco, San Francisco, California 94107, USA.

Nature, 2012, vol. 490, issue 7420, 350-351

Abstract: A genetic analysis of viruses infecting participants in an HIV vaccine trial indicates that the vaccine is more protective against viruses that have variations at specific sites in the viral envelope. See Letter p.417

Date: 2012
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/490350a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:490:y:2012:i:7420:d:10.1038_490350a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/490350a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().